Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JINS HoldingsFRA:5F3 95 Earnings Yield (Joel Greenblatt) % is 9.00% as of Feb. 2026, which is 161% above its 10-year median of 3.45. GuruFocus rates FRA:5F3 with a GF Score™ of 95/100 and a GF Value™ of €35.19 (Fairly Valued). Among 848 Medical Devices & Instruments companies, JINS Holdings ranks better than 83.14% on this metric.
JINS Holdings's Enterprise Value for the quarter that ended in Feb. 2026 was €637.5 Mil.
JINS Holdings's EBIT for the trailing twelve months (TTM) ended in Feb. 2026 was €63.0 Mil. JINS Holdings's Earnings Yield (Joel Greenblatt) for the quarter that ended in Feb. 2026 was 9.00%.
The historical rank and industry rank for JINS Holdings's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
FRA:5F3'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 1.4 Med: 3.45 Max: 10.27
Current: 7.76
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of JINS Holdings was 10.27%. The lowest was 1.40%. And the median was 3.45%.
FRA:5F3's Earnings Yield (Joel Greenblatt) % is ranked better than 83.14% of 848
companies
in the Medical Devices & Instruments industry
Industry Median: 1.14
vs FRA:5F3: 7.76
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. JINS Holdings's Forward Rate of Return (Yacktman) % for the quarter that ended in Feb. 2026 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
JINS Holdings Earnings Yield (Joel Greenblatt) % Related Terms
JINS Holdings Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for JINS Holdings's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, JINS Holdings's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JINS Holdings Earnings Yield (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JINS Holdings's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where JINS Holdings's Earnings Yield (Joel Greenblatt) % falls into.
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
JINS Holdingss Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Aug. 2025 is calculated as
JINS Holdings's EBIT for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €63.0 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 9.00% mean?
JINS Holdings (FRA:5F3) has a Earnings Yield (Joel Greenblatt) % of 9.00% as of Feb. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on JINS Holdings and its competitors. This is 161% above median its historical median of 3.45. Over the past decade, JINS Holdings' Earnings Yield (Joel Greenblatt) % has ranged from 1.40 to 10.27. According to the industry distribution chart, JINS Holdings ranks #143 out of 848 companies in the Medical Devices & Instruments industry, placing it in the top 16.9%.
Is JINS Holdings' Earnings Yield (Joel Greenblatt) % too high?
JINS Holdings' current Earnings Yield (Joel Greenblatt) % of 9.00% is 161% above median its 10-year median of 3.45. Over the past 10 years, this metric has ranged from a low of 1.40 to a high of 10.27. The Medical Devices & Instruments industry median Earnings Yield (Joel Greenblatt) % is 1.14. JINS Holdings' value of 9.00% is 689.5% above this industry median. Based on the distribution chart, JINS Holdings ranks #143 out of 848 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, JINS Holdings has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does JINS Holdings' Earnings Yield (Joel Greenblatt) % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JINS Holdings ranks #143 out of 848 companies for Earnings Yield (Joel Greenblatt) %. This places JINS Holdings in the top 17% of its industry — outperforming the majority of peers. The industry median Earnings Yield (Joel Greenblatt) % is 1.14. JINS Holdings' value of 9.00% is 689.5% above this benchmark. Historically, JINS Holdings' own Earnings Yield (Joel Greenblatt) % has ranged from 1.40 to 10.27 over the past decade. While the company's 10-year median is 3.45 vs. the industry median of 1.14, JINS Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median Earnings Yield (Joel Greenblatt) % among Medical Devices & Instruments companies is 1.14, based on 848 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JINS Holdings's current Earnings Yield (Joel Greenblatt) % of 9.00% is 689.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on JINS Holdings and its competitors. For the Medical Devices & Instruments industry, the median Earnings Yield (Joel Greenblatt) % is 1.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JINS Holdings's current Earnings Yield (Joel Greenblatt) % is 9.00%, which is 161% above median its own 10-year median of 3.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JINS Holdings stock overvalued right now?
Based on GuruFocus' analysis, JINS Holdings (FRA:5F3) is currently considered Fairly Valued. The stock's GF Value™ is €35.19, compared to a current price of €33.80 — trading 3.9% below its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 9.00%, which is 161% above median its 10-year median of 3.45 and 689.5% above the Medical Devices & Instruments industry median of 1.14. JINS Holdings' overall GF Score™ is 95/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For JINS Holdings (FRA:5F3), the current Earnings Yield (Joel Greenblatt) % is 9.00% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JINS Holdings (FRA:5F3) Overvalued in 2026?
Based on GuruFocus' analysis, JINS Holdings stock appears to be undervalued.
The current stock price of €33.80 is trading 3.9% below its estimated GF Value™ of €35.19.
GuruFocus considers JINS Holdings to be Fairly Valued.
Key valuation signals for FRA:5F3:
Earnings Yield (Joel Greenblatt) %: 9.00% (161% above median its 10-year median of 3.45)
GF Value™: €35.19 vs. price of €33.80 (3.9% below fair value)
Industry Position: 689.5% above the Medical Devices & Instruments median (#143 of 848)
No single metric tells the full story. See the FRA:5F3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JINS Holdings Inc is an eyewear retailer that manufactures and sells private-label fashion eyeglasses and sunglasses. It offers prescription eyeglasses and nonprescription fashion or functional eyeglasses. Its inventory is on the shelves, and it charges flat rates with generally no additional charges or options for lens features. Jin has more than 300 stores in Japan as well as locations in China, Taiwan, and the United States. Stores are typically located in high-traffic areas such as shopping centers, malls, and train stations.
95GF Score
Get the complete analysis for FRA:5F3
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5F3 has been successfully added to your 
